Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

48.50
Delayed Data
As of Apr 20
 -0.35 / -0.72%
Today’s Change
29.95
Today|||52-Week Range
50.05
+21.71%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Supernus Pharmaceuticals Inc have a median target of 54.00, with a high estimate of 70.00 and a low estimate of 42.00. The median estimate represents a +11.34% increase from the last price of 48.50.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Supernus Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.24
Sales
$87.8M
Reporting Date
May 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.41%
 
 
 
 
 
 
Growthannually 73.68%
 
 
 
 
 
 

Sales

Growthquarterly -0.71%
 
 
 
 
 
 
Growthannually 31.88%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.